Neurocrine Biosciences (NBIX) Tax Provisions (2019 - 2021)
Historic Tax Provisions for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2021 value amounting to $8.0 million.
- Neurocrine Biosciences' Tax Provisions rose 150000.0% to $8.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.8 million, marking a year-over-year increase of 8377.32%. This contributed to the annual value of $9.5 million for FY2019, which is 120547.95% up from last year.
- Per Neurocrine Biosciences' latest filing, its Tax Provisions stood at $8.0 million for Q3 2021, which was up 150000.0% from $15.2 million recorded in Q2 2021.
- Neurocrine Biosciences' 5-year Tax Provisions high stood at $15.2 million for Q2 2021, and its period low was -$4.9 million during Q1 2021.
- For the 3-year period, Neurocrine Biosciences' Tax Provisions averaged around $3.3 million, with its median value being $2.6 million (2020).
- Within the past 5 years, the most significant YoY rise in Neurocrine Biosciences' Tax Provisions was 150000.0% (2021), while the steepest drop was 42666.67% (2021).
- Neurocrine Biosciences' Tax Provisions (Quarter) stood at $4.6 million in 2019, then crashed by 89.2% to $500000.0 in 2020, then soared by 1500.0% to $8.0 million in 2021.
- Its Tax Provisions was $8.0 million in Q3 2021, compared to $15.2 million in Q2 2021 and -$4.9 million in Q1 2021.